Fly News Breaks for September 29, 2016
VRTX
Sep 29, 2016 | 08:13 EDT
After Vertex lowered its 2016 Orkambi revenue guidance, RBC Capital analyst Michael Yee says that the news "was not a surprise." The analyst remains upbeat on the company's triple CF treatment, and he recommends buying the stock on weakness. He keeps an Outperform rating on the shares.
News For VRTX From the Last 2 Days